Raceanisodamine (7β-Hydroxyhyoscyamine) is the active ingredient of Chinese herbal extracts that has vasoactive activity used to treat acute disseminated intravascular coagulation in patients in bacteremic shock.
This report contains market size and forecasts of Raceanisodamine in global, including the following market information:
Global Raceanisodamine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Raceanisodamine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Raceanisodamine companies in 2021 (%)
The global Raceanisodamine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Raceanisodamine include Jiangxi Jinyue Pharmaceutical, Fujian Province Leephick Pharmaceutic Industry, Jiangsu Pengyao Pharmaceutical, Hangzhou Minsheng Pharmaceutical, Jiangsu Tasly Diyi Pharmaceutical, Chifeng Weikang Biochemical Pharmaceutical, Shanghai Kaibao Xinyi Pharmaceutical and China Resources Double-Crane Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Raceanisodamine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Raceanisodamine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Raceanisodamine Market Segment Percentages, by Type, 2021 (%)
Injection
Tablet
Drops
Global Raceanisodamine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Raceanisodamine Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Pharmacy
Other
Global Raceanisodamine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Raceanisodamine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Raceanisodamine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Raceanisodamine revenues share in global market, 2021 (%)
Key companies Raceanisodamine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Raceanisodamine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Jiangxi Jinyue Pharmaceutical
Fujian Province Leephick Pharmaceutic Industry
Jiangsu Pengyao Pharmaceutical
Hangzhou Minsheng Pharmaceutical
Jiangsu Tasly Diyi Pharmaceutical
Chifeng Weikang Biochemical Pharmaceutical
Shanghai Kaibao Xinyi Pharmaceutical
China Resources Double-Crane Pharmaceutical